Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study.
Lekpa FK, Poulain C, Wendling D, Soubrier M, De Bandt M, Berthelot JM, Gaudin P, Toussirot E, Goupille P, Pham T, Sellam J, Bruckert R, Paul M, Farrenq V, Claudepierre P; Club Rhumatismes et Inflammation.
Lekpa FK, et al.
Arthritis Res Ther. 2012 Mar 9;14(2):R53. doi: 10.1186/ar3766.
Arthritis Res Ther. 2012.
PMID: 22404969
Free PMC article.